‘No need to rush’: Senator warns of FDA’s shortcuts to full approval of COVID-19 vaccine

‘No need to rush’: Senator warns of FDA’s shortcuts to full approval of COVID-19 vaccine (Archived)

“I see no need to rush the FDA approval process for any of the three COVID-19 vaccines. Expediting the process appears to only serve the political purpose of imposing and enforcing vaccine mandates,” Mr. Johnson wrote in the letter, a copy of which was obtained by The Washington Times.

U.S. Surgeon General Vivek Murthy told “Fox News Sunday” that moving the Pfizer vaccine from “emergency” to “full approval” would make mandates more appealing.

Former FDA Commissioner Scott Gottlieb, who is on the Pfizer board of directors, also said the full approval will prompt more vaccine mandates.

Related:

Gottlieb’s Pfizer Announces $1.95 Billion Deal with Feds for COVID-19 Vaccine

Just hours before the Pfizer vaccine news became public, Gottlieb appeared on CNBC’s Squawk Box to explain that any vaccine will need to be administered on an annual basis.

Source.

Some more notes that I made, about Gottlieb and the coronavirus, in March 2020.

Long-Term Studies Of COVID-19 Vaccines Hurt By Placebo Recipients Getting Immunized

February 19, 2021:

Long-Term Studies Of COVID-19 Vaccines Hurt By Placebo Recipients Getting Immunized

Dr. Steven Goodman, a clinical trials specialist at Stanford University, says losing those control groups makes it more difficult to answer some important questions about COVID-19 vaccines.

“We don’t know how long protections lasts,” he says. “We don’t know efficacy against variants — for which we definitely need a good control arm — and we also don’t know if there are any differences in any of these parameters by age or race or infirmity.”

H/T: This is nuts, Moderna & Pfizer intentionally lost the clinical trial control group testing vaccine efficacy and safety